Latest filing published 10 Oct 2025 for NeoVolta Inc., €4,299.
Filing timeline
BuySaleInsider track record
No signal scores available.
Brent Willson: trading record in brief
Brent Willson is a declared insider at 2 companies; the most frequent names are NeoVolta Inc. and Rapid Therapeutic Science Laboratories, Inc. In total, 3 filings cover trades dated from 29 January 2018 to 8 October 2025.
No open-market purchase appears, only 1 sale worth €4,299. Other entries cover 1 share grant and 1 option exercise. Since January 2025: no purchases and 1 sale on the market.
The newest entry dates from 10 October 2025: an open-market sale of €4,299, in NeoVolta Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brent Willson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 shares@ US$0.01100.0% of flowCommon StockSEC:0001683168-25-007510:0
- 50,000 sharesCommon StockSEC:0001683168-23-000031:0
- 750,000 shares0Common StockSEC:0001393905-18-000070:0
3 of 3 declarations